ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,459.10
1.11%
US Tech 100
18,512.80
0.99%
Dow Jones
40,589.34
1.64%
Brent Oil
79.745
-2.20%
Bitcoin
68,061.30
3.45%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Abionyx Pharma (ABNX) Quote

Abionyx Pharma

Abionyx Pharma (ABNX)

EU
1.238
0.004
(0.32%)
Closed July 26 11:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.238
Bid
1.22
Ask
1.246
Volume
6,981
1.21 Day's Range 1.242
0.91 52 Week Range 1.482
Market Cap
40.184M
Previous Close
1.234
Open
1.21
Last Trade
400
@
1.238
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
67,566
Shares Outstanding
32,459,012
Dividend Yield
-
PE Ratio
-11.44
Earnings Per Share (EPS)
-0.11
Revenue
4.74M
Net Profit
-3.52M

About Abionyx Pharma

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.abionyx.com
Headquarters
Balma, Haute-garonne, Fra
Founded
1970
Abionyx Pharma is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ABNX. The last closing price for Abionyx Pharma was 1.23 €. Over the last year, Abionyx Pharma shares have traded in a share price range of 0.91 € to 1.482 €.

Abionyx Pharma currently has 32,459,012 shares outstanding. The market capitalization of Abionyx Pharma is 40.05 € million. Abionyx Pharma has a price to earnings ratio (PE ratio) of -11.44.

ABNX Latest News

More News

ABIONYX Pharma : Bilan semestriel du contrat de liquidité contracté avec la Société TP ICAP (Europe) SA

Regulatory News: Au titre du contrat de liquidité confié par la société ABIONYX Pharma (Paris:ABNX) à la Société TP ICAP (Europe) SA, à la date du 28 juin 2024, les moyens suivants figuraient au...

July 04 2024
Business Wire

ABIONYX Pharma : Information relative au nombre total de droits de vote et d’actions composant le capital social

Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de...

July 03 2024
Business Wire

ABIONYX Carries out Successfully a Capital Increase With Cancellation of Preferential Subscription Rights for the Benefit of a Category of Persons Through the Issue of Shares With Warrants for an Amount of c.€3.4 Million

c.€3.4 million by issuing shares with warrants Subscription price: €1.37 for one share with warrants 1 warrant gives entitlement to 1 share to be issued at a price of €3 Exercise period: 3 years...

July 01 2024
Business Wire

ABIONYX Pharma announces unanimous approval of all resolutions put to the vote at its Combined General Meeting

Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - PEA PME eligible), a new generation biotech company dedicated to the discovery and development of innovative therapies based on the world’s...

June 27 2024
Business Wire

ABIONYX décide une augmentation de capital avec suppression du droit préférentiel de souscription au profit d’une catégorie de personnes par émission d’ABSA d’un montant d’environ 3,4M€

Montant d’environ 3,4 millions d'euros par émission d’actions assorties de bons de souscription d’actions (« ABSA ») Prix de souscription : 1,37 euro pour une ABSA 1 BSA donne droit à 1 action à...

June 19 2024
Business Wire

ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis

Based on encouraging Phase 2a data and a productive pre-IND Type B meeting with U.S. Food and Drug Administration (FDA), ABIONYX Pharma intends to file an Investigational New Drug application...

June 13 2024
Business Wire

ABIONYX Pharma has completed a successful pre-IND meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis

Based on encouraging Phase 2a data and a productive pre-IND Type B meeting with U.S. Food and Drug Administration (FDA), ABIONYX Pharma intends to file an Investigational New Drug application...

June 13 2024
Business Wire

ABIONYX : Information relative au nombre total de droits de vote et d’actions composant le capital social

Regulatory News: ABIONYX Pharma (Paris:ABNX): Place de cotation : Euronext Paris, Compartiment C Code ISIN : FR0012616852 Date Nombre de titres composant le capital en circulation Nombre total de...

June 04 2024
Business Wire
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.012-0.961.251.251.2189281.24362943DE
40.0685.811965811971.171.251.11166661.20523845DE
120.19819.03846153851.041.4821.01675661.24804724DE
260.0080.6504065040651.231.4820.91579951.17588369DE
520.0383.166666666671.21.4820.91714791.22173941DE
1560.21220.66276803121.0263.570.911748201.98811235DE
2600.908275.1515151520.333.570.22578371.36853706DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CGTXCognition Therapeutics Inc
$ 3.57
(50.63%)
4.01M
RNAZTransCode Therapeutics Inc
$ 0.355
(20.09%)
5.82M
NAMSNewAmsterdam Pharma Company NV
$ 22.13
(17.34%)
16.46k
TCTuanChe Ltd
$ 1.93
(16.97%)
640
YIBOPlanet Image International Ltd
$ 3.38
(15.95%)
46.19k
VTVTvTv Therapeutics Inc
$ 12.0634
(-43.10%)
25.21k
TGLTreasure Global Inc
$ 1.436
(-22.38%)
46.69k
LUXHLuxUrban Hotels Inc
$ 0.1526
(-20.10%)
1.18M
CEROCERo Therapeutics Holdings Inc
$ 0.21
(-17.97%)
1.19M
SLNASelina Hospitality PLC
$ 0.0261
(-13.00%)
15.8M
SLNASelina Hospitality PLC
$ 0.0261
(-13.00%)
15.8M
RNAZTransCode Therapeutics Inc
$ 0.355
(20.09%)
5.82M
CGTXCognition Therapeutics Inc
$ 3.57
(50.63%)
4.01M
TLTiShares 20 plus Year Treasury Bond
$ 92.98
(-0.01%)
3.9M
NVDANVIDIA Corporation
$ 113.03
(-0.03%)
2.38M

Discussion

View Full Feed
burdbasket burdbasket 4 minutes ago
I know. Ive been around a long time. Just making a point.
HIRU
RickNagra RickNagra 4 minutes ago
Oh wow. Today was a great day. And tomorrow also will be a great day.
DBMM
Hunterdave Hunterdave 5 minutes ago
Fuk no
They don't care what the price is now.
Fuk any Americans that try to make money from them NOW.
Not counting those who've sold already.
Tell me I'm wrong
IGPK
poguemahone poguemahone 5 minutes ago
Really?

Did you happen to notice how much AVXL is up in a week?

Yes, but I also happen to notice how much it’s down from it’s all-time high. Or, does that not matter?
AVXL
Eagle1 Eagle1 5 minutes ago
Benz so if you are, and I know you are a business broker, does any deals get done Always on time?

Asking because I work in a $100+ Billion-dollar industry that helps many people in the entire world that keeps people alive and never does things get done on time.

Just say
GDVM
RC_702 RC_702 5 minutes ago
Who’s CONfused? That’s cute! My money is on you and I’m not going to hedge any bets.

Splice and dice and ignore the question of what firsthand knowledge about the company do you have? Where exactly have they looked? Still waiting for your answer. I’m not going to hold my breath.
SFRX
zeusgodmd zeusgodmd 5 minutes ago
Just saw it on cnbc
RNAZ
Fiscall Fiscall 6 minutes ago
It's certainly interesting to consider the potential implications of the share issuance, especially in light of the current market conditions and the company's cash position. Let’s connect the dots based on the information available:

Current Context and Cash Position
Current Ca
LWLG
LTListener LTListener 6 minutes ago
Undoubtedly these shares must be extremely valuable….

Or either it is Halloween.
RSPI
noradio noradio 6 minutes ago
He works with MMs who naked short these OTCs.
HIRU
Dano02VFR Dano02VFR 7 minutes ago
Oh wow.
ERBB
janice shell janice shell 7 minutes ago
I say get rid of that '4 hours ago' crap......put a time in there like normal people do..........

I rarely agree with you, but I do agree about that. You can be reading along in batch mode and have no idea how many posts are left for you to read.

At least not without m
Chartmaster Chartmaster 7 minutes ago
Who da thought? 3M up 23% in one day? Simply Amazing!! 200 day MA at 117 is pullback support now, man after I 3x it on those calls I was pricing the Aug 120 calls at 3.00, tried to buy 2.50, no fill now 9.00! This is just a warm up of how stocks will rip till year end esp after the rate cut
MMM
LTListener LTListener 7 minutes ago
Same most recent 10-q….

ResolutionRx, was organized January 11, 2023 as a wholly-owned subsidiary of RespireRx. We are also evaluating whether to organize our EndeavourRx business unit, in part or in whole, into one or more subsidiaries that would conduct R&D of our neuromodulator p
RSPI
gedi8 gedi8 8 minutes ago
You too turbo
RXMD
ali g ali g 9 minutes ago
Thx bruv
DSCR
burdbasket burdbasket 9 minutes ago
So you have some sort of sick enjoyment when people experience their trading dollars being reduced? You must be one hell of a guy. BTW, I’m riding free shares. Looking for a penny which is 30k profit (not a dollar). And you would be cheering against me???? Wow! Hell of a man.
HIRU
neomania neomania 9 minutes ago
How naive are you. This is a SCAM.
NSAV
beer$$money beer$$money 9 minutes ago
$VXIT For the record no " janitorial service" was provided.
3RD PARTY LAB PRE-TEST ASSESSMENT
Third party laboratory testing is the only unbiased process to test if your efforts are truly working and resolving all the indoor and environmental challenges.
Simply, our third-party
VXIT
JoeForkeyBolo JoeForkeyBolo 10 minutes ago
Pumpers are busy looking for new MONI investors who are easily duped by the tweets and rumors of an impending acquisition of yet another high-revenue company. That's an easy hook for a company that has never generated revenue.

Looks like they might need some help finding new suckers,
MONI
zakattack zakattack 10 minutes ago
No one has explained why gncp is still around it's been dark expert market for 2 years and growing woth no end in sight why keep this around? Or is it that he's to lazy to file paperwork to get rid of it?
GNCP
rodeoup rodeoup 10 minutes ago
All I know is that when the California gold rush hit in 1848 right next to the newly 100% purchased Mt Vernon Gold Mine, gold was going for $18 an ounce, which translates to about $700 at present day prices. I bought my first gold ounce at $336 an ounce, and today it closed at $2401 an ounce. I real
NBRI
ScottishTexan ScottishTexan 10 minutes ago
Other login - lol. Go ahead and buy more. Dennis will be your best friend.
DPLS

Your Recent History

EU
ABNX
Abionyx Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved